@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-JP3JL5F6-0 skos:prefLabel "Dérivés de la scopolamine"@fr, "Scopolamine Derivatives"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-K3LWL3XJ-K . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-K3LWL3XJ-K mesh:allowableQualifier jvr:-HQRFT0C6-B, jvr:-SBNWSM1T-R, jvr:-XV06LPML-W, jvr:-NB0XHT3S-N, jvr:-M63HSDM7-1, jvr:-FWD2BGQ0-9, jvr:-BT300B3G-Q, jvr:-TJHVZCRZ-0, jvr:-NHL3D2X0-S, jvr:-H7K65Q8S-Z, jvr:-S0CS1X5R-5, jvr:-NKM836P1-M, jvr:-R0ZCQ8X6-J, jvr:-W6SQV79N-S, jvr:-CB30NGKB-3, jvr:-THHNVC7V-3, jvr:-Q3979798-W, jvr:-L6C0XPHT-4, jvr:-D0F21513-5, jvr:-T9HQD7ST-J, jvr:-G30ZJ446-J, jvr:-WK5F724J-1, jvr:-R3QWLHRG-V, jvr:-G4R176S9-J, jvr:-NFTHND7Q-8 ; skos:altLabel "K0813KQM3V"@fr, "K0813KQM3V"@en, "RTN51LK7WL"@fr, "RTN51LK7WL"@en, "VDR09VTQ8U"@fr, "VDR09VTQ8U"@en, "7110-59-0 (Iodide)"@fr, "7110-59-0 (Iodide)"@en, "N-Méthyl-scopolamine"@fr, "6106-46-3 (Nitrate)"@fr, "6106-46-3 (Nitrate)"@en, "18067-13-5 (Methylsulfate)"@fr, "18067-13-5 (Methylsulfate)"@en, "13265-10-6 (N-Methylscopolamine)"@fr, "13265-10-6 (N-Methylscopolamine)"@en, "155-41-9 (Bromide)"@fr, "155-41-9 (Bromide)"@en, "R044N53C06"@fr, "R044N53C06"@en, "N-Méthylscopolamine"@fr, "N-Méthylscopolammonium"@fr, "Methscopolamine"@en ; skos:hiddenLabel "N-Methylscopolamine Methylsulfate"@en, "Bromure de N-méthyl-scopolammonium"@fr, "Ulix"@en, "Hyoscine Methiodide"@en, "DD-234"@en, "DD-234"@fr, "N-Methylscopolamine Bromide"@en, "Iodure de N-méthyl-scopolammonium"@fr, "Methylscopolammonium Methylsulfate"@en, "Iodure de N-méthylscopolammonium"@fr, "N-Methylscopolamine Iodide"@en, "Bromure de N-méthylscopolammonium"@fr, "Scopolamine Methylbromide"@en, "Hyoscine Methobromide"@en, "Skopyl"@en, "Méthiodure de hyoscine"@fr, "N-Methylscopolamine Nitrate"@en, "Méthobromure de hyoscine"@fr, "Methylscopolamine Nitrate"@en, "N-Methylscopolamine Methylchloride"@en, "N-Methylscine Methylsulfate"@en, "DD234"@fr ; skos:prefLabel "N-Methylscopolamine"@en, "N-Méthyl-scopolammonium"@fr ; a skos:Concept, mesh:Descriptor ; owl:sameAs ; skos:inScheme jvr: ; dc:established "1998-01-01"^^xsd:date ; skos:broader jvr:-JP3JL5F6-0 ; mesh:pharmacologicalAction jvr:-TW1NK90Q-W ; dc:modified "2016-05-31"^^xsd:date ; dc:created "1997-06-20"^^xsd:date ; skos:definition "A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors."@en . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TW1NK90Q-W skos:prefLabel "Parasympatholytiques"@fr, "Parasympatholytics"@en ; a mesh:Descriptor, skos:Concept .